Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Broad Effectiveness: Study With Aripiprazole [Phase 3]
Phase 3 study evaluating aripiprazole investigates overall effectiveness in schizophrenia and schizoaffective disorder; the trial status is …
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 clinical trial evaluating the effects of adding aripiprazole to olanzapine in overweight patients with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices [Phase 3]
This Clinical Trial Update reports the completion of a Phase 3 study evaluating aripiprazole for schizophrenia and schizoaffective disorder …
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. [Phase 4]
A Phase 4 trial evaluated aripiprazole as dual therapy in chronic stable schizophrenia or schizoaffective disorder; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease [Phase 4]
Phase 4 safety study of Paliperidone ER in patients with liver disease has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older People [NA]
This completed clinical trial from Dartmouth-Hitchcock Medical Center evaluated health care management and rehabilitation skills training fo…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Thinking Skills for Work in Severe Mental Illness [NA]
Clinical trial update indicating completion of a study on thinking skills for work in severe mental illness, covering multiple psychiatric c…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia [Phase 4]
This Phase 4 clinical trial update reports the long-term efficacy and safety results of risperidone microspheres in participants with schizo…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia [NA]
This completed clinical trial investigated interventions aimed at improving functional outcomes and persistent symptoms in schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders [Phase 4]
Phase 4 clinical trial update reporting efficacy and safety of Risperidone long-acting injectable in schizophrenia-spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 trial evaluating the maintenance of efficacy of Risperidone Long Acting Injectable (R-LAI) in schizophrenia or schizoaffective disor…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Open-label Study of Curcumin C-3 Complex in Schizophrenia [Phase 1, Phase 2]
An open-label Phase 1/2 study of Curcumin C-3 Complex in schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation [Phase 4]
This Phase 4 trial evaluated whether amantadine can reduce prolactin elevations in patients treated with risperidone long-acting injectable …
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder [Phase 2]
Phase 2 clinical trial evaluating the STIRR intervention for people with co-occurring mental illness and substance use disorders; results we…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics [Phase 4]
Phase 4 trial assessing efficacy and tolerability of switching to ziprasidone from other antipsychotics in schizophrenia and schizoaffective…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills [NA]
A completed clinical trial comparing olanzapine and aripiprazole examines the impact on learning vocational skills in individuals with schiz…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
This update reports results from a youth-focused trial evaluating the effectiveness and tolerability of a second-generation antipsychotic ac…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients [NA]
A completed clinical trial evaluating self-regulation strategies to improve exercise behavior in people with schizophrenia or schizoaffectiv…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Effect of Single Dose Intranasal Insulin On Cognitive Function [Phase 4]
Update on a Phase 4 trial evaluating whether a single dose of intranasal insulin improves cognitive function in schizophrenia and schizoaffe…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: L-carnosine for Schizophrenia [NA]
The clinical trial database entry reports completion of a study evaluating L-carnosine for schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder [Phase 4]
NIMH-sponsored Phase 4 clinical trial comparing antipsychotics for metabolic problems in schizophrenia and schizoaffective disorder with res…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 study evaluating switching to lurasidone for schizophrenia or schizoaffective disorder; results were posted after completion in 2012…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy [NA]
This entry reports the completion of a clinical trial evaluating the impact of cognitive-behavioral therapy on recovery from psychosis in in…
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study assessed whether Panax ginseng can enhance the efficacy of antipsychotics in schizophrenia and schizoaffec…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning [Phase 3]
Phase 3 trial evaluating the impact of galantamine hydrobromide as an adjunct to electroconvulsive therapy on mood and cognitive outcomes in…